October 24, 2018
ARLINGTON, Va. — Healthcare Distribution Alliance (HDA) President and CEO John M. Gray issued a statement in response to the enactment of the SUPPORT for Patients and Communities Act.
“HDA applauds the White House and Congress for taking significant action to protect Americans by advancing meaningful solutions to address the opioid epidemic through the passage and enactment of the SUPPORT for Patients and Communities Act. This new law offers a comprehensive response to the complex public health crisis that our country faces, including two key provisions to improve the monitoring of controlled substances. We applaud members of Congress, including Chairman Grassley (R-Iowa), Sens. Feinstein (D-Calif.), Hassan (D-N.H.), Capito (R-W.Va.) and Durbin (D-Ill.) for their work to advance critical provisions related to increasing transparency within the supply chain and with the DEA.
“Specifically, the law will enhance data sharing and coordination among pharmaceutical distributors, state and federal regulators and law enforcement. It also will broaden distributor access to critical information as part of the Drug Enforcement Administration’s (DEA) Automation of Reports and Consolidated Orders System (ARCOS). Moreover, the law establishes a centralized database for suspicious order reporting that provides information to the states for further investigation and necessary action.
“HDA and its distributor members look forward to continued collaboration with the White House and Congress as we remain focused on advancing a comprehensive approach to reversing the opioid abuse epidemic in our country.”
The Healthcare Distribution Alliance (HDA) represents primary pharmaceutical distributors — the vital link between the nation’s pharmaceutical manufacturers and more than 200,000 pharmacies, hospitals, long-term care facilities, clinics and others nationwide. Since 1876, HDA has helped members navigate regulations and innovations to get the right medicines to the right patients at the right time, safely and efficiently. The HDA Research Foundation, HDA’s non-profit charitable foundation, serves the healthcare industry by providing research and education focused on priority healthcare supply chain issues.